22
Participants
Start Date
October 31, 2009
Primary Completion Date
January 31, 2010
Study Completion Date
January 31, 2010
lopinavir/ritonavir
Each participant received three sequential doses of lopinavir/ritonavir: 400/100 mg twice daily (2 heat-stable 200/50 mg tablets BID), 200/150 mg twice daily (1 heat-stable 200/50 mg tablet BID plus 1 ritonavir 100 mg capsule BID), and 200/50 mg twice daily (1 heat-stable 200/50 mg tablet BID). Each dosing phase lasted for 7 days and each phase was separated by a 7-day wash-out period.
St Stephen's Centre, Chelsea and Westminster Hospital, London
Lead Sponsor
Kirby Institute
OTHER_GOV